EUVIMEDEUVIMED entdecken
Crossref

Association of gestational hepatitis B virus infection and antiviral therapy with pregnancy outcomes: A retrospective study

Kaiyi Mao, Pingying Jiang, Weiqi Cai, Yongxu Lin, Yu Zhou, Dan Li iD

International Journal of Gynecology & Obstetrics · 2024

DOI: 10.1002/ijgo.15716 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2024. Verfasst von Kaiyi Mao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Fujian Medical University Union Hospital, Fuzhou, China. Hauptthemen laut MEDLINE: Antiviral Agents, Pregnancy Complications, Infectious, Pregnancy Outcome, Hepatitis B. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Fujian Clinical Research Center for Digestive System Tumors and Upper Gastrointestinal Diseases, China, The National Key Clinical Specialty Construction Projects of Fujian Province, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To explore the relationships between gestational hepatitis B virus (HBV) infection, antiviral therapy, and pregnancy outcomes.

Methods

We retrospectively selected hepatitis B surface antigen (HBsAg)‐positive pregnant women hospitalized for delivery at Fujian Medical University Affiliated Hospital from October 1, 2016 to October 1, 2020. The control group included randomly selected healthy pregnant women hospitalized for delivery during the same time.

Results

Overall, 1115 participants were enrolled and grouped into control ( n = 380) and HBsAg‐positive groups ( n = 735), which were further divided into groups I ( n = 407; low viral load), II ( n = 207; high viral load without antiviral therapy), and III ( n = 121; high viral load with antiviral therapy). Pregnant women with HBV were positively correlated with the incidence of intrahepatic cholestasis of pregnancy (ICP) (adjusted odds ratio [aOR] 5.1, 95% confidence interval [CI] 2.62–9.92, P < 0.001), neonatal jaundice (aOR 10.56, 95% CI 4.49–24.83, P < 0.001), and neonatal asphyxia (aOR 5.03, 95% CI 1.46–17.27, P = 0.01). Aspartate aminotransferase (AST) greater than the upper limit of normal (ULN) was an independent risk factor for increased ICP incidence (aOR 3.49, 95% CI 1.26–9.67, P = 0.019). Antiviral therapy considerably reduced HBV DNA and improved liver function. High viral load and antiviral therapy did not correlate significantly with adverse pregnancy outcomes ( P < 0.05).

Conclusion

Pregnant women with HBV have significantly elevated incidence of ICP, neonatal jaundice, and neonatal asphyxia not significantly correlated with viral load. AST greater than ULN independently increases the risk of ICP. Antiviral therapy effectively reduces viral replication and improves liver function without increasing the risk of adverse outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsPregnancy Complications, InfectiousPregnancy OutcomeHepatitis BViral LoadHumansFemalePregnancyRetrospective StudiesAdultCholestasis, IntrahepaticChinaHepatitis B Surface AntigensHepatitis B virusInfant, NewbornCase-Control StudiesJaundice, NeonatalPregnancy Complications

Stichwörter der Autor:innen

adverse pregnancy outcomesantiviral therapyaspartate transaminasehepatitis B virus infectionviral load

Substanzen

Antiviral AgentsHepatitis B Surface Antigens

Autor:innen und Institutionen

  • Department of Gastroenterology, Fujian Medical University Union Hospital, Fuzhou, China.
  • Department of Obstetrics and Gynecology, Fujian Medical University Union Hospital, Fuzhou, China.
  • Fujian Clinical Research Center for Digestive System Tumors and Upper Gastrointestinal Diseases, Fuzhou, China.

ORCID-Profile: Dan Li

Förderung

  • Fujian Clinical Research Center for Digestive System Tumors and Upper Gastrointestinal Diseases, China
  • The National Key Clinical Specialty Construction Projects of Fujian Province, China

Zitieren

APA

Mao, K., Jiang, P., Cai, W., Lin, Y., Zhou, Y., & Li, D. (2024). Association of gestational hepatitis B virus infection and antiviral therapy with pregnancy outcomes: A retrospective study. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.15716

Vancouver

Mao K, Jiang P, Cai W, Lin Y, Zhou Y, Li D. Association of gestational hepatitis B virus infection and antiviral therapy with pregnancy outcomes: A retrospective study. International Journal of Gynecology & Obstetrics. 2024. doi:10.1002/ijgo.15716

BibTeX
@article{Mao2024,
  author = {Mao, Kaiyi and Jiang, Pingying and Cai, Weiqi and Lin, Yongxu and Zhou, Yu and Li, Dan},
  title = {Association of gestational hepatitis B virus infection and antiviral therapy with pregnancy outcomes: A retrospective study},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2024},
  doi = {10.1002/ijgo.15716}
}
Kostenlos starten →